KC
Koneru Chiranjivee Rammohan Rao
About Koneru Chiranjivee Rammohan Rao
Data last updated:
Koneru Chiranjivee Rammohan Rao has 16 years in corporate governance. Holds Director role. Currently with 1 company, including Krs Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Krs Pharmaceuticals Private Limited at ₹54.79 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 02 Nov 2009 | 2000 | ₹54.79 Cr (FY 2025) | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Koneru Chiranjivee Rammohan Rao
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Koneru Chiranjivee Rammohan Rao
Koneru Chiranjivee Rammohan Rao has 16 years in corporate governance. Holds Director role. Currently with 1 company, including Krs Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Krs Pharmaceuticals Private Limited at ₹54.79 Cr (FY 2025).
Koneru Chiranjivee Rammohan Rao is associated with 1 company as Director, including Krs Pharmaceuticals Private Limited (₹54.79 Cr).
Koneru Chiranjivee Rammohan Rao has expertise in General Business.
Koneru Chiranjivee Rammohan Rao has 16 years in corporate governance.
By reported revenue, the largest current company of Koneru Chiranjivee Rammohan Rao is Krs Pharmaceuticals Private Limited, with revenue of ₹54.79 Cr (FY 2025).
Koneru Chiranjivee Rammohan Rao currently holds positions at 1 company: Krs Pharmaceuticals Private Limited (₹54.79 Cr).